Press Releases | Philochem

Philochem announces a publication entitled: “Data-Independent Acquisition of HLA Class I Peptidomes on the Q Exactive Mass Spectrometer Platform”

by last | Aug 18, 2017 | 2017, Press Releases

Philochem announces a publication entitled: “Data-Independent Acquisition of HLA Class I Peptidomes on the Q Exactive Mass Spectrometer Platform” Link to Paper

Philogen S.p.A. enters into Multi-Target research agreement with Boehringer Ingelheim in the field of DNA-encoded chemistry.

by last | Jul 20, 2017 | 2017, Press Releases

Press release Philogen_20 Juy 2017

Philogen S.p.A. announces participation to the ““FOCIS Annual Meeting 2017”, June 14 – 17, 2017, Chicago, USA

by last | May 25, 2017 | 2017, Press Releases

PR_FOCIS 2017

Philogen S.p.A announces the publication in the prestigious Chemistry

by last | May 10, 2017 | 2017, Press Releases

1_PR_Chemistry 2017Philogen S.p.A announces the publication in the prestigious Chemistry: A European Journal of a communication entitled: “A specific and covalent JNK-1 ligand selected from an encoded self-assembling chemical library”

Philogen S.p.A. announces participation in “XXIV EFMC INTERNATIONAL SYMPOSIUM ON MEDICINAL CHEMISTRY”, 28 August – 1 September 2016, Manchester, UK

by last | Aug 11, 2016 | 2016, Press Releases

Press release_Philogen 11 August 2016

Philogen S.p.A. announced that they have entered into a collaboration

by last | Aug 3, 2016 | 2016, Press Releases

Philogen S.p.A. announced that they have entered into a collaboration, option and license agreement with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to discover and develop a new class of immunomodulatory therapeutics....